Sumit Aggarwal - Oct 16, 2024 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Sumit Aggarwal
Stock symbol
ELOX
Transactions as of
Oct 16, 2024
Transactions value $
$0
Form type
4
Date filed
10/17/2024, 04:01 PM
Previous filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELOX Common Stock Award $0 +165K +3346.86% $0.00 170K Oct 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This restricted stock award was made under the Issuer's 2018 Equity Incentive Plan and vests as to 25% on October 16, 2025 and in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.

Remarks:

On December 1, 2022, the Issuer effected a 1-for-40 reverse stock split. The share counts herein reflect the reverse stock split.